The Roles of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists and Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors in Decreasing the Occurrence of Adverse Cardiorenal Events in Patients With Type 2 Diabetes

Diabetes mellitus is a metabolic disorder characterized by increased serum glucose due to errors in insulin production or response. The prevalence of diabetes mellitus has continued to rise globally over the years, with roughly 7079 persons per 100,000 expected to be impacted by 2030. A vast number...

Descripción completa

Detalles Bibliográficos
Autores principales: Shami, Dalia, Sousou, John M, Batarseh, Einas, Alazrai, Laith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901266/
https://www.ncbi.nlm.nih.gov/pubmed/36751181
http://dx.doi.org/10.7759/cureus.33484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901266/
https://www.ncbi.nlm.nih.gov/pubmed/36751181
http://dx.doi.org/10.7759/cureus.33484

Ejemplares similares